Primary |
Drug Use For Unknown Indication |
44.1% |
Insomnia |
31.9% |
Product Used For Unknown Indication |
11.0% |
Alcoholic Psychosis |
7.1% |
Cardiac Failure Chronic |
1.6% |
Depression |
1.2% |
Arteriosclerosis Obliterans |
0.8% |
Constipation |
0.8% |
Angina Pectoris |
0.4% |
Colon Cancer |
0.4% |
Coronary Arterial Stent Insertion |
0.4% |
Hypertension |
0.4% |
|
Pulmonary Embolism |
21.9% |
Suicide Attempt |
12.5% |
Death |
6.3% |
Intentional Overdose |
6.3% |
Neuroleptic Malignant Syndrome |
6.3% |
Prothrombin Time Shortened |
6.3% |
Rash |
6.3% |
Shock |
6.3% |
Toxic Epidermal Necrolysis |
6.3% |
Tricuspid Valve Incompetence |
6.3% |
Gastrointestinal Haemorrhage |
3.1% |
Hepatitis Acute |
3.1% |
Pneumonia Aspiration |
3.1% |
Viral Infection |
3.1% |
Water Intoxication |
3.1% |
|
Secondary |
Drug Use For Unknown Indication |
24.8% |
Insomnia |
22.3% |
Depression |
12.5% |
Suicide Attempt |
7.5% |
Drug Exposure During Pregnancy |
4.7% |
Parkinson's Disease |
3.7% |
Constipation |
3.3% |
Intentional Overdose |
2.8% |
Diabetic Neuropathy |
2.2% |
Product Used For Unknown Indication |
2.0% |
Alcoholic Psychosis |
1.9% |
Gastritis |
1.9% |
Pain In Extremity |
1.9% |
Bipolar Disorder |
1.4% |
Anxiety |
1.2% |
Back Pain |
1.2% |
Cough |
1.2% |
Hypertension |
1.2% |
Productive Cough |
1.2% |
Systemic Lupus Erythematosus |
0.9% |
|
Suicide Attempt |
11.9% |
Prothrombin Time Shortened |
10.2% |
Sepsis |
10.2% |
Toxic Epidermal Necrolysis |
8.5% |
Deafness Neurosensory |
6.8% |
Pseudomembranous Colitis |
6.8% |
Muscle Spasms |
5.1% |
Somnolence |
5.1% |
Tachypnoea |
5.1% |
Delirium |
3.4% |
Intentional Overdose |
3.4% |
Multiple Drug Overdose Intentional |
3.4% |
Shock |
3.4% |
Sudden Death |
3.4% |
Urinary Incontinence |
3.4% |
White Blood Cell Count Increased |
3.4% |
Agranulocytosis |
1.7% |
Homicide |
1.7% |
Ileus |
1.7% |
Intentional Drug Misuse |
1.7% |
|
Concomitant |
Drug Use For Unknown Indication |
28.0% |
Insomnia |
13.8% |
Hypertension |
8.1% |
Rheumatoid Arthritis |
7.0% |
Depression |
5.5% |
Constipation |
4.7% |
Prophylaxis |
4.7% |
Schizophrenia |
3.8% |
Gastritis |
2.7% |
Pyrexia |
2.7% |
Nutritional Support |
2.6% |
Product Used For Unknown Indication |
2.5% |
Cancer Pain |
2.5% |
Diabetes Mellitus |
1.9% |
Pneumonia Aspiration |
1.7% |
Parkinson's Disease |
1.6% |
Immunosuppressant Drug Therapy |
1.6% |
Pain |
1.6% |
Metastatic Renal Cell Carcinoma |
1.5% |
Pneumonia |
1.4% |
|
White Blood Cell Count Decreased |
8.4% |
Pyrexia |
7.8% |
Rhabdomyolysis |
7.3% |
Tremor |
7.3% |
Hepatic Function Abnormal |
6.7% |
Pancytopenia |
6.7% |
Palpitations |
5.6% |
Suicide Attempt |
5.0% |
Vomiting |
5.0% |
Liver Disorder |
4.5% |
Rash |
4.5% |
Somnolence |
4.5% |
Parkinsonism |
3.9% |
Pneumonia Aspiration |
3.9% |
Malaise |
3.4% |
Platelet Count Decreased |
3.4% |
Renal Impairment |
3.4% |
White Blood Cell Count Increased |
3.4% |
Death |
2.8% |
Palmar-plantar Erythrodysaesthesia Syndrome |
2.8% |
|